While the main CF airway pathologic feature is severe neutrophilic inflammation, recent studies have suggested a role for type 2 inflammation, in part driven by the adaptive immune system via CD4+ Th2 cells activated by chronic allergen exposure (1–5). This evidence concerns the gene CD4 and cystic fibrosis.